Records containing: Peanut Allergy
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-09-04Single Center, Placebo Controlled Clinical Study in Desensitization vs Tolerance Induction in Peanut Allergy Subjects
-
CLINICAL_TRIALS study record update · 2019-07-26An Open-label Phase I Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects
-
CLINICAL_TRIALS study record update · 2019-06-12Peanut Sublingual Immunotherapy and Induction of Clinical Tolerance in Peanut Allergic Children (SLIT Tolerance TLC) {Sublingual Immunotherapy for Peanut Allergy}
-
CLINICAL_TRIALS study record update · 2019-04-18Reactive Doses and Times During Oral Food Challenge (OFC) to Peanut
-
CLINICAL_TRIALS study record update · 2018-08-24Explorative Open Phase II-study, Food Allergy Suppression Therapy During Protection With Xolair
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-08-07Changing Mindsets About Oral Immunotherapy for Peanut Allergies Via Informing Patients That Symptoms Are a Sign of Treatment Efficacy: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2018-07-03The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy
-
CLINICAL_TRIALS study record update · 2017-07-12Effects of Omalizumab on Peanut Allergen Induced Cellular and Clinical Responses in Peanut Allergic Adults
-
CLINICAL_TRIALS study record update · 2017-05-03Phase 2 Study of Omalizumab in Oral Peanut Desensitization
-
CLINICAL_TRIALS study record update · 2017-03-10Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
-
CLINICAL_TRIALS study record update · 2017-03-03Evaluating the Placement of a Peanut Immunotherapy Dissolving Film in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2017-01-20Oral Peanut Immunotherapy
-
CLINICAL_TRIALS study record update · 2016-12-01ClinicalTrials.gov study NCT02979600
-
CLINICAL_TRIALS study record update · 2016-11-18Visual Recognition of Allergens by Allergic Patients and/or Their Parents
-
CLINICAL_TRIALS study record update · 2015-10-20ARACHILD: A Multicentric, Double Blind Placebo-controlled Pilot Protocol to Study the Efficacy and Safety of an Epicutaneous Immunotherapy in Children Allergic to Peanut
-
CLINICAL_TRIALS study record update · 2015-07-10A First-in-human, Randomized, Double Blind, Placebo Controlled, Single-centre Study to Assess the Safety and Tolerability of HAL-MPE1 in Patients With Peanut Allergy
-
CLINICAL_TRIALS study record update · 2015-05-27Evaluation of Allergenicity of Hypoallergenic Peanut Product in Peanut Allergic Subjects.
-
CLINICAL_TRIALS study record update · 2015-02-20Xolair Enhances Oral Desensitization in Peanut Allergic Patients
-
CLINICAL_TRIALS study record update · 2015-01-14Efficacy and Safety of High-dose Peanut Oral Immunotherapy With Factors Predicting Outcome
-
CLINICAL_TRIALS study record update · 2014-12-03Dendritic Cell Responses to Viral Stimulation in Peanut Allergic Subjects Undergoing Peanut Oral Immunotherapy
-
CLINICAL_TRIALS study record update · 2014-09-10Walnut Oral Immunotherapy for Tree Nut Allergy-CHOP
-
CLINICAL_TRIALS study record update · 2014-01-27Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers
-
CLINICAL_TRIALS study record update · 2012-07-23A Phase II, Randomized, Double Blind, Placebo-controlled, Parallel Design, Dose Ranging, Multi-center Trial of Four Levels of Exposure of QGE031 s.c. for 16 Weeks in Subjects Aged 18-50 Years of Age With Peanut Allergy
-
CLINICAL_TRIALS study record update · 2012-03-23Epicutaneous Immunotherapy (EPIT) for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Safety Study in Adult and Pediatric Subjects